Study of ABCB1 polymorphism (C3435T) in HIV-1-infected individuals from South India

British Journal of Clinical Pharmacology

Volumn 65, Issue 5, 2008, Pages 791-792

  Bakshi, Siddharth ^b   Ramachandran, Geetha ^b   Ramesh, Karunaianandham ^b   Hemanthkumar, Agibothu K ^b   Anitha, Suresh ^b   Padmapriyadarsini, Chandrasekaran ^b   Narendran, Gopalan ^b   Menon, Pradeep A ^b   Rajasekaran, Sikhamani ^c   Swaminathan, Soumya ^a,b  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c Government Hospital for Thoracic Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; NEVIRAPINE;

ABCB1 GENE; ADULT; AFRICAN AMERICAN; CAUCASIAN; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; JAPAN; LETTER; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 42149106741     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03093.x     Document Type: Letter

References (10)

1. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Eichelbaum M, Brinkmann U. Functional polymorphisms of the human multidrug resistance gene. Multiple sequence variations and correlation of one allele P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000 97 : 3473 8.
2. Hitzl M, Drescher S, van der Kuip H, Schaefeler E, Fischer J, Schwab M, Eichelbaum M, Fromm MF. The C3435T mutation in the human MDR1 gene is associated with altered efflux of P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001 11 : 293 8.
3. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer H, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002 359 : 30 6.
4. Csajka C, Marzolini C, Fattinger K, Decosterd LA, Fellay J, Telenti A, Biollaz J, Buclin T. Population pharmacokinetics and effects of EFV in patients with human immunodeficiency virus infection. Clin Pharmacol Ther 2003 73 : 20 30.
5. Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM, Schwab M. Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 2001 358 : 383 4.
6. Ameyaw MM, Regateiro F, Li T, Liu X, Tariq M, Mobarek A, Thornton N, Folayan GO, Githang'a J, Indalo A, Ofori-Adjei D, Prince-Evans DA, McLeod HL. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001 11 : 217 21.
7. Ramachandran G, Hemanth Kumar AK, Swaminathan S, Venkatesan P, Kumaraswami V, Greenblatt DJ. Simple and rapid liquid chromatography method for determination of EFV in plasma. J Chromatogr B Anal Technol Biomed Life Sci 2006 835 : 131 5.
8. Ramachandran G, Hemanth Kumar AK, Kumaraswami V, Swaminathan S. Simple liquid chromatography method for simultaneous determination of zidovudine and NVP in plasma. J Chromatogr B Anal Technol Biomed Life Sci 2006 843 : 339 43.
9. Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schakel U, Ehninger G, Schaich M. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 2002 62 : 4955 62.
10. Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP. Pharmacogenetics of EFV and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS 2004 18 : 2391 400.